3/22
09:24 pm
zvra
Zevra Ties NPC Testing Push To Valuation Gap And New CFO [Yahoo! Finance]
Low
Report
Zevra Ties NPC Testing Push To Valuation Gap And New CFO [Yahoo! Finance]
3/20
05:17 pm
zvra
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/20
04:30 pm
zvra
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
3/18
06:13 am
zvra
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements [Yahoo! Finance]
Medium
Report
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements [Yahoo! Finance]
3/16
08:03 am
zvra
Zevra Therapeutics (ZVRA) is now covered by BTIG Research. They set a "buy" rating and a $23.00 price target on the stock.
Medium
Report
Zevra Therapeutics (ZVRA) is now covered by BTIG Research. They set a "buy" rating and a $23.00 price target on the stock.
3/16
07:41 am
zvra
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million [Yahoo! Finance]
Medium
Report
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million [Yahoo! Finance]
3/16
07:30 am
zvra
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
Low
Report
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
3/11
06:13 pm
zvra
Zevra Therapeutics (ZVRA) was upgraded by
Weiss Ratings from "sell (d+)" to "hold (c+)".
Low
Report
Zevra Therapeutics (ZVRA) was upgraded by
Weiss Ratings from "sell (d+)" to "hold (c+)".
3/11
05:42 pm
zvra
Is Zevra Therapeutics (ZVRA) Pricing Reflecting Its Strong Multi-Year Share Price Performance [Yahoo! Finance]
Low
Report
Is Zevra Therapeutics (ZVRA) Pricing Reflecting Its Strong Multi-Year Share Price Performance [Yahoo! Finance]
3/10
06:29 pm
zvra
Why Zevra Therapeutics Stock Zoomed 21% Higher Today [Yahoo! Finance]
Medium
Report
Why Zevra Therapeutics Stock Zoomed 21% Higher Today [Yahoo! Finance]
3/10
10:57 am
zvra
Zevra Therapeutics: Miplyffa Uptake Validates Rare Disease Commercial Model [Seeking Alpha]
Low
Report
Zevra Therapeutics: Miplyffa Uptake Validates Rare Disease Commercial Model [Seeking Alpha]
3/10
10:09 am
zvra
Zevra Therapeutics (ZVRA) was given a new $23.00 price target by Guggenheim.
Low
Report
Zevra Therapeutics (ZVRA) was given a new $23.00 price target by Guggenheim.
3/10
09:03 am
zvra
Zevra jumps 19% after Q4 EPS tops consensus estimates [Seeking Alpha]
Medium
Report
Zevra jumps 19% after Q4 EPS tops consensus estimates [Seeking Alpha]
3/9
04:42 pm
zvra
Zevra Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Zevra Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/9
04:05 pm
zvra
Zevra Reports Fourth Quarter and Full Year 2025 Financial Results
High
Report
Zevra Reports Fourth Quarter and Full Year 2025 Financial Results
3/7
10:38 am
zvra
New Zevra CFO Appointment Highlights Rare Disease Focus And Valuation Gap [Yahoo! Finance]
Low
Report
New Zevra CFO Appointment Highlights Rare Disease Focus And Valuation Gap [Yahoo! Finance]
3/5
08:08 am
zvra
Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer [Yahoo! Finance]
Low
Report
Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer [Yahoo! Finance]
3/5
07:30 am
zvra
Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer
Low
Report
Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer
3/2
07:30 am
zvra
Zevra Therapeutics Announces Details for Q4 and Full Year 2025 Financial Results Call
Medium
Report
Zevra Therapeutics Announces Details for Q4 and Full Year 2025 Financial Results Call
2/25
12:31 pm
zvra
Is Zevra Therapeutics (ZVRA) Pricing Reflect Its Strong DCF Upside Potential? [Yahoo! Finance]
Low
Report
Is Zevra Therapeutics (ZVRA) Pricing Reflect Its Strong DCF Upside Potential? [Yahoo! Finance]
2/25
07:30 am
zvra
Zevra Therapeutics to Present at the Citizens Life Sciences Conference
Low
Report
Zevra Therapeutics to Present at the Citizens Life Sciences Conference
2/18
01:51 pm
zvra
Zevra Therapeutics Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Low
Report
Zevra Therapeutics Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
2/4
08:29 am
zvra
Zevra Therapeutics Presents Positive New Real-World Data on MIPLYFFA® in Patients with Neimann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium™ [Yahoo! Finance]
Medium
Report
Zevra Therapeutics Presents Positive New Real-World Data on MIPLYFFA® in Patients with Neimann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium™ [Yahoo! Finance]
2/4
07:30 am
zvra
Zevra Therapeutics Presents Positive New Real-World Data on MIPLYFFA® in Patients with Neimann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium™
Low
Report
Zevra Therapeutics Presents Positive New Real-World Data on MIPLYFFA® in Patients with Neimann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium™
2/2
07:41 am
zvra
Zevra Therapeutics to Ring Nasdaq Stock Market Opening Bell on Monday, February 9, 2026 [Yahoo! Finance]
Medium
Report
Zevra Therapeutics to Ring Nasdaq Stock Market Opening Bell on Monday, February 9, 2026 [Yahoo! Finance]